186 related articles for article (PubMed ID: 38365745)
1. The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.
Di Nardo M; Astigiano S; Baldari S; Pallotta MM; Porta G; Pigozzi S; Antonini A; Emionite L; Frattini A; Valli R; Toietta G; Soddu S; Musio A
J Exp Clin Cancer Res; 2024 Feb; 43(1):49. PubMed ID: 38365745
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development.
Sarogni P; Palumbo O; Servadio A; Astigiano S; D'Alessio B; Gatti V; Cukrov D; Baldari S; Pallotta MM; Aretini P; Dell'Orletta F; Soddu S; Carella M; Toietta G; Barbieri O; Fontanini G; Musio A
J Exp Clin Cancer Res; 2019 Mar; 38(1):108. PubMed ID: 30823889
[TBL] [Abstract][Full Text] [Related]
3. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells.
Li J; Feng W; Chen L; He J
J Int Med Res; 2016 Feb; 44(1):67-74. PubMed ID: 26637483
[TBL] [Abstract][Full Text] [Related]
5. SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis.
Zhou P; Xiao N; Wang J; Wang Z; Zheng S; Shan S; Wang J; Du J; Wang J
Cancer Lett; 2017 Jan; 385():39-45. PubMed ID: 27826041
[TBL] [Abstract][Full Text] [Related]
6. siRNA-mediated knockdown of SMC1A expression suppresses the proliferation of glioblastoma cells.
Yang Y; Zhang Z; Wang R; Ma W; Wei J; Li G
Mol Cell Biochem; 2013 Sep; 381(1-2):209-15. PubMed ID: 23754617
[TBL] [Abstract][Full Text] [Related]
7. Mutant cohesin drives chromosomal instability in early colorectal adenomas.
Cucco F; Servadio A; Gatti V; Bianchi P; Mannini L; Prodosmo A; De Vitis E; Basso G; Friuli A; Laghi L; Soddu S; Fontanini G; Musio A
Hum Mol Genet; 2014 Dec; 23(25):6773-8. PubMed ID: 25080505
[TBL] [Abstract][Full Text] [Related]
8. Spectrum and consequences of SMC1A mutations: the unexpected involvement of a core component of cohesin in human disease.
Mannini L; Liu J; Krantz ID; Musio A
Hum Mutat; 2010 Jan; 31(1):5-10. PubMed ID: 19842212
[TBL] [Abstract][Full Text] [Related]
9. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
[TBL] [Abstract][Full Text] [Related]
10. Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.
Ma Z; Lin M; Li K; Fu Y; Liu X; Yang D; Zhao Y; Zheng J; Sun B
Int J Clin Exp Pathol; 2013; 6(5):862-9. PubMed ID: 23638217
[TBL] [Abstract][Full Text] [Related]
11. The multiple facets of the SMC1A gene.
Musio A
Gene; 2020 Jun; 743():144612. PubMed ID: 32222533
[TBL] [Abstract][Full Text] [Related]
12. CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies.
Fazio G; Gaston-Massuet C; Bettini LR; Graziola F; Scagliotti V; Cereda A; Ferrari L; Mazzola M; Cazzaniga G; Giordano A; Cotelli F; Bellipanni G; Biondi A; Selicorni A; Pistocchi A; Massa V
J Cell Physiol; 2016 Mar; 231(3):613-22. PubMed ID: 26206533
[TBL] [Abstract][Full Text] [Related]
13. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.
Pan XW; Gan SS; Ye JQ; Fan YH; Hong Υ; Chu CM; Gao Y; Li L; Liu X; Chen L; Huang Y; Xu H; Ren JZ; Yin L; Qu FJ; Huang H; Cui XG; Xu DF
Int J Oncol; 2016 Nov; 49(5):1963-1972. PubMed ID: 27667360
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
[TBL] [Abstract][Full Text] [Related]
16. Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Zhou Q; Perakis SO; Ulz P; Mohan S; Riedl JM; Talakic E; Lax S; Tötsch M; Hoefler G; Bauernhofer T; Pichler M; Gerger A; Geigl JB; Heitzer E; Speicher MR
Genome Med; 2020 Feb; 12(1):20. PubMed ID: 32087735
[TBL] [Abstract][Full Text] [Related]
17. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of SMC1A promotes hepatocellular carcinoma cell proliferation and migration.
Zhang Y; Yi F; Wang L; Wang Z; Zhang N; Wang Z; Li Z; Song X; Wei S; Cao L
Int J Biol Sci; 2018; 14(9):1081-1089. PubMed ID: 29988990
[TBL] [Abstract][Full Text] [Related]
19. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
[TBL] [Abstract][Full Text] [Related]
20. SMC1A facilitates gastric cancer cell proliferation, migration, and invasion via promoting SNAIL activated EMT.
Liu Y; Fang X; Wang Q; Xiao D; Zhou T; Kang K; Peng Z; Ren F; Zhou J
BMC Gastroenterol; 2023 Aug; 23(1):268. PubMed ID: 37537540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
